BACKGROUND AND PURPOSE: Stroke incidence and prevalence estimates in developing countries should include stroke cases not presenting to hospital. We performed door-to-door stroke case ascertainment in Durango Municipality, Mexico, to estimate stroke incidence and prevalence and to determine the error made by only ascertaining hospital cases. METHODS:Between September 2008 and March 2009, 1996 housing units were randomly sampled to screen for stroke in Durango Municipality residents 35 years of age and older. Field workers utilized a validated screening tool. Those screening positive were referred to a neurologist for history and examination and a head CT scan. Prevalence and cumulative incidence from the door-to-door surveillance were calculated and compared with previously reported hospitalization rates during the same defined time. RESULTS:Respondents included 2437 subjects from 1419 homes. The refusal rate was 3.8%. Twenty subjects had verified or probable stroke. The prevalence of probable or verified stroke was 7.7 per 1000 (95% CI, 4.3 per 1000-11.2 per 1000). Five patients had a stroke during the time of the hospital surveillance, yielding a cumulative incidence of 232.3 per 100 000 (95% CI, 27.8-436.9). Two of the 5 cases were captured by door-to-door surveillance but not by hospital surveillance. CONCLUSIONS: This study provides the first community-based stroke prevalence and incidence estimates in Mexico. The wide confidence intervals, despite the large number of surveyed housing units, suggest the need for more advanced sampling strategies for stroke surveillance in the developing world.
RCT Entities:
BACKGROUND AND PURPOSE:Stroke incidence and prevalence estimates in developing countries should include stroke cases not presenting to hospital. We performed door-to-door stroke case ascertainment in Durango Municipality, Mexico, to estimate stroke incidence and prevalence and to determine the error made by only ascertaining hospital cases. METHODS: Between September 2008 and March 2009, 1996 housing units were randomly sampled to screen for stroke in Durango Municipality residents 35 years of age and older. Field workers utilized a validated screening tool. Those screening positive were referred to a neurologist for history and examination and a head CT scan. Prevalence and cumulative incidence from the door-to-door surveillance were calculated and compared with previously reported hospitalization rates during the same defined time. RESULTS: Respondents included 2437 subjects from 1419 homes. The refusal rate was 3.8%. Twenty subjects had verified or probable stroke. The prevalence of probable or verified stroke was 7.7 per 1000 (95% CI, 4.3 per 1000-11.2 per 1000). Five patients had a stroke during the time of the hospital surveillance, yielding a cumulative incidence of 232.3 per 100 000 (95% CI, 27.8-436.9). Two of the 5 cases were captured by door-to-door surveillance but not by hospital surveillance. CONCLUSIONS: This study provides the first community-based stroke prevalence and incidence estimates in Mexico. The wide confidence intervals, despite the large number of surveyed housing units, suggest the need for more advanced sampling strategies for stroke surveillance in the developing world.
Authors: T L Robertson; H Kato; G G Rhoads; A Kagan; M Marmot; S L Syme; T Gordon; R M Worth; J L Belsky; D S Dock; M Miyanishi; S Kawamoto Journal: Am J Cardiol Date: 1977-02 Impact factor: 2.778
Authors: C S Uribe; I Jiménez; M O Mora; A Arana; J L Sánchez; L Zuluaga; A Muñoz; J Tobón; E A Cardona; O F Buriticá; L A Villa Journal: Rev Neurol Date: 1997-07 Impact factor: 0.870
Authors: A Nicoletti; V Sofia; S Giuffrida; A Bartoloni; F Bartalesi; M L Bartolo; S L Fermo; V Cocuzza; H Gamboa; E Salazar; A Reggio Journal: Stroke Date: 2000-04 Impact factor: 7.914
Authors: O H Del Brutto; L Idrovo; A Mosquera; E Díaz-Calderón; R Santibáñez; C Navas; F Cuesta Journal: Rev Neurol Date: 2004 Aug 16-31 Impact factor: 0.870
Authors: Lewis B Morgenstern; Melinda A Smith; Lynda D Lisabeth; Jan M H Risser; Ken Uchino; Nelda Garcia; Paxton J Longwell; David A McFarling; Olubumi Akuwumi; Areej Al-Wabil; Fahmi Al-Senani; Devin L Brown; Lemuel A Moyé Journal: Am J Epidemiol Date: 2004-08-15 Impact factor: 4.897
Authors: Diego López-Mena; Miguel García-Grimshaw; Sergio Saldivar-Dávila; Laura Elena Hernandez-Vanegas; María Del Mar Saniger-Alba; Alonso Gutiérrez-Romero; Roger Carrillo-Mezo; Hector Eduardo Valdez-Ruvalcaba; Vanessa Cano-Nigenda; Fernando Daniel Flores-Silva; Carlos Cantú-Brito; Ana María Santibañez-Copado; Jose-Luis Diaz-Ortega; Santa Elizabeth Ceballos-Liceaga; Luis Manuel Murillo-Bonilla; Ana Isabel Sepulveda-Núñez; Verónica García-Talavera; Eduardo Gonzalez-Guerra; Ricardo Cortes-Alcala; Hugo Lopez-Gatell; Guillermo Carbajal-Sandoval; Gustavo Reyes-Terán; Sergio Iván Valdés-Ferrer; Antonio Arauz Journal: Neurology Date: 2022-03-11 Impact factor: 11.800
Authors: Maria Lazo-Porras; Antonio Bernabe-Ortiz; Robert H Gilman; William Checkley; Liam Smeeth; J Jaime Miranda Journal: Lancet Reg Health Am Date: 2021-10-30
Authors: Annette L Fitzpatrick; Quang Van Ngo; Kiet A Ly; Thanh G N Ton; W T Longstreth; Tung T Vo; Kristen Heitzinger; Chien H Pham; David L Tirschwell Journal: J Epidemiol Glob Health Date: 2012-09
Authors: Luz M Moyano; Silvia M Montano; Percy Vilchez Barreto; Narcisa Reto; Luis Larrauri; Nicanor Mori; Mario Cornejo-Olivas; Erik Guevara-Silva; Fernando Urizar; Enrique Najar; Ricardo Gamboa; Cintya Azabache; Raquel Herrer Ticse; Lucia Bolivar-Herrada; Alex Doud; Peggy Martinez; J Jaime Miranda; Joseph R Zunt; Hector H García Journal: PLoS One Date: 2021-07-29 Impact factor: 3.240